Bergabunglah dengan Buletin Kami
Bergabunglah dengan daftar pelanggan kami untuk mendapatkan artikel terkini, update dan penawaran khusus langsung di kotak masuk Anda
The approval covers Pitolisant Tablets 4.45 mg and 17.8 mg, bioequivalent to Wa...
The facility received 11 observations during the USFDA inspection conducted fro...
State and UT Drugs Controllers asked to identify manufacturers, marketers, dist...
LSSSDC Skillverse 2026 will focus on workforce requirements, Industry 5.0, Glob...
The combination is intended for patients who have previously received at least o...
The collaboration aims to develop new quantum algorithms that could accelerate t...
Platform brings regulatory intelligence, labelling, gap assessments, health aut...
Triggered by recent high profile operations involving counterfeit semaglutide i...
The decision marks the third NMPA-approved indication for an ivonescimab-contain...
The proceeds will also be used to fund Remepy’s lead product Hybridopa’s global ...
BASF’s Personal Care business introduces Floragenist Rose and Floragenist Bloss...
BIRAC’s pavilion features start-ups working on medical devices, rehabilitation ...
Stuart Preston explains how metal detection supports contamination control, pro...
The transaction is structured through a share purchase agreement with SEVER Life...
The arrangement enables Sentynl to acquire exclusive US commercial rights to alv...
Pharmexcil data shows growth across formulations, bulk drugs, vaccines and surg...